Search - tctmd.com

Displaying 941 - 960 of 1604

Sort: Relevancy | Date

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

News Daily News

LAA 封堵器说明中凸显本领域发展的关键问题

July 02, 2015

News Daily News

之前无明确冠心病的患者中 CTO 相对常见

Nicole Lou

June 30, 2015

News Daily News

Las OTC son Relativamente Frecuentes en Pacientes Sin EAC Conocida Anteriormente

Nicole Lou

June 30, 2015

News Daily News

CTOs Relatively Frequent in Patients Without Previously Known CAD

Nicole Lou

June 30, 2015

News Daily News

一项研究探索了经股动脉TAVR后早出院的安全性

L.A. McKeown

June 24, 2015

News Daily News

Un Estudio Explora la Seguridad del Alta Precoz Post- TAVR Transfemoral

L.A. McKeown

June 24, 2015

News Daily News

Study Explores Safety of Early Discharge After Transfemoral TAVR

L.A. McKeown

June 24, 2015

News Daily News

La FDA Aprueba 2 Nuevos Sistemas TAVR para Pacientes de Alto Riesgo e Inoperable

Yael L. Maxwell

June 24, 2015

News Daily News

FDA 批准 2 项新 TAVR 系统用于治疗高危、无法手术的患者

Yael L. Maxwell

June 24, 2015

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Daily News

导管传送基因疗法在晚期心力衰竭患者中表现出积极的迹象

June 23, 2015

News Daily News

Una Terapia Génica administrada por Catéter es Positiva en el Manejo de la Insuficiencia Cardíaca Avanzada

June 23, 2015

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

News Daily News

TAVR 术后中度至重度二尖瓣关闭不全提示死亡风险上升

Todd Neale

June 18, 2015

News Daily News

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Todd Neale

June 18, 2015

News Daily News

La Regurgitación Mitral Moderada-Severa Señala un Mayor Riesgo de Mortalidad Post-TAVR

Todd Neale

June 18, 2015

News Daily News

在一项单中心、非随机研究中，Lotus瓣膜的一些指标超过CoreValve

L.A. McKeown

June 17, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

Advertisement

Statement on LAA Closure Highlights Key Issues for Growing Field

LAA 封堵器说明中凸显本领域发展的关键问题

之前无明确冠心病的患者中 CTO 相对常见

Las OTC son Relativamente Frecuentes en Pacientes Sin EAC Conocida Anteriormente

CTOs Relatively Frequent in Patients Without Previously Known CAD

一项研究探索了经股动脉TAVR后早出院的安全性

Un Estudio Explora la Seguridad del Alta Precoz Post- TAVR Transfemoral

Study Explores Safety of Early Discharge After Transfemoral TAVR

La FDA Aprueba 2 Nuevos Sistemas TAVR para Pacientes de Alto Riesgo e Inoperable

FDA 批准 2 项新 TAVR 系统用于治疗高危、无法手术的患者

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

导管传送基因疗法在晚期心力衰竭患者中表现出积极的迹象

Una Terapia Génica administrada por Catéter es Positiva en el Manejo de la Insuficiencia Cardíaca Avanzada

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

TAVR 术后中度至重度二尖瓣关闭不全提示死亡风险上升

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

La Regurgitación Mitral Moderada-Severa Señala un Mayor Riesgo de Mortalidad Post-TAVR

在一项单中心、非随机研究中，Lotus瓣膜的一些指标超过CoreValve

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content